ArticleeLife2025
ORMDL3 restrains type I interferon signaling and anti-tumor immunity by promoting RIG-I degradation.
Qi Zeng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ArticleeLife2025
Qi Zeng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.